Stockreport

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies [Yahoo! Finance]

Aligos Therapeutics, Inc. - Common stock  (ALGS) 
PDF company focused on developing novel therapeutics to address unmet medical needs in liver and viral diseases, today announced three oral presentations and one poster pres [Read more]